ANALYSIS: Medicinal cannabis has been legal since 2016 and while more than one million Australians have been prescribed cannabis products, the industry continues to struggle for profitability.
ANALYSIS: Balancing inflation risks against growth risks.
Former Bank of England governor defends Covid response, spruiks climate change.
ANALYSIS: The vagueness of Silverlake’s NZ Rugby pitch is hardly an endorsement for private equity.
ANALYSIS: Despite USA’s commitment to democracy it is still trying to extradite Julian Assange.
ANALYSIS: With economists having predicted nine of the last five recessions, how worried should investors be this time?
ANALYSIS: Jacinda Ardern will urge US to join CPTPP but progress is unlikely.
Price paid was the loss of innovation legacy.
ANALYSIS: Regulators are allowing advisers to inflate projected returns in a way banned overseas.
Carry On: Gulfstream, Dassault add to range, lower fares prediction.